MadeCELL is a biotechnology startup founded in 2020 in France. The company specializes in developing innovative softwares for Cell, Gene and Tissue therapies and offers the first integrated management software for the production and management of pharmaceutical quality of innovative therapy drugs and cell therapy products. Their dedication to revolutionizing the biotechnology and health industries has attracted attention, leading to a Non Equity Assistance investment at 01 August 2020 from AGORANOV.
General Information
Get notified when MadeCELL moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track MadeCELL
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
France Market
Biotechnology
About MadeCELL
Taxonomy: Pharmaceutical software, Therapy production management, Cell therapy, Gene therapy, Tissue therapy, Innovative drug management, Quality control, Integrated management software
Services & Products
Target Customers
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Non Equity Assistance | •••••• | 1 |
|
01 Aug 2020 |
MadeCELL Alternatives & Competitors
Providing comprehensive, round-the-clock care with specialized therapies and expert rehabilitation s...
FAQ About MadeCELL
Don't just browse. Track.
Signal Tracker monitors MadeCELL and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.